Riskpilot← Back to searchSign inGet full accessEclosion AB
ABActiveOrg 5594310186Sankt Paulsgatan 22 AManufacture of paper and paperboard · NACE 1712Est. 20230 employees
Revenue 2024
SEK 0
EBITDA margin
—
-3% vs 2023
Equity ratio
31.7%
Financial strength
Net profit 2024
SEK -1,6M
-5% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,6M | -3% |
| Net profit | SEK -1,6M | -5% |
| Total assets | SEK 2M | +7701% |
| Equity | SEK 618K | +4657% |
| Employees | 0 | — |
Legal name
Eclosion AB
Org number
5594310186
Legal form
Aktiebolag
NACE code
1712 · Manufacture of paper and paperboard
Founded
19 april 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget har till ändamål att utveckla, förädla och tillgängliggöra användandet av biobaserade material från växtriket applicerat på hållbara och cirkulära system till företrädesvis förpackningsindustrin samt därmed förenlig verksamhet.
Address
Sankt Paulsgatan 22 A
Email
liselotte.tingvall@futurelabandpartners.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −1 509 | −1 558 |
| Depreciation & amort. | — | −21 |
| EBIT | −1 509 | −1 578 |
| Net financials | — | 1 |
| Profit before tax | −1 509 | −1 578 |
| Tax | — | — |
| Net profit | −1 509 | −1 578 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 25 | 1 950 |
| Equity | 13 | 618 |
| Long-term debt | — | — |
| Short-term debt | 12 | 1 332 |
| Total debt | 12 | 1 332 |
EBITDA margin
-155795500.0%
This company
15.8%
Market median
-986047568% vs market
20232024
Equity ratio
31.7%
This company
38.2%
Market median
+17% vs market
20232024
Return on equity
-255.1%
This company
18.4%
Market median
-1486% vs market
20232024
Net profit margin
-157752000.0%
This company
8.1%
Market median
-1947555656% vs market
20232024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232024
Debt / equity
2.15×
This company
0.62×
Market median
-247% vs market
20232024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-04-19 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GL Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
AJ Chief Auditor | Chief Auditor | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
FutureLab & Partners AB | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FutureLab & Partners AB
Eclosion AB Board members of Eclosion AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gudrun Liselotte Tingvall | Chief Executive Officer | 0 companies |
| Anders Joakim Toivo Taaler | Chief Auditor | 0 companies |
| Carl Magnus Ingemar Leijonborg | Chairman | 0 companies |
| Peter Ulrik Eriksson | Chairman | 0 companies |
| Rolf Andreas Sjödin | Deputy Board Member | 0 companies |
| Maria Elisabeth Olofsson | Board of Directors | 0 companies |
| Lars Olof Hellman | Board of Directors | 0 companies |